CJEU: Proof of vaccine defect
Where there is a lack of scientific consensus, the proof of the defect of the vaccine and of a causal link between the defect and the damage suffered may be made out by serious, specific and consistent evidence.
The temporal proximity between the administering of a vaccine and the occurrence of a disease, the lack of personal and familial history of the person vaccinated and the existence of a significant number of reported cases of the disease occurring following such vaccines being administered may, where applicable, constitute sufficient evidence to make out such proof
Latest News from
EU trade schemes promote economic development and human rights22/01/2018 14:10:00
A report published jointly by the EC and the European External Action Service shows the positive impact of the European Union's duty-rebate schemes on developing economies.
Countering illegal hate speech online22/01/2018 13:25:00
The third evaluation of the Code of Conduct on countering illegal online hate speech carried out by NGOs and public bodies shows that IT companies removed on average 70% of illegal hate speech notified to them.
ESMA updates transparency calculations for MiFID II/MiFIR22/01/2018 11:51:00
The ESMA has published an extended version of the MiFID II/MiFIR transitional transparency calculations (TTC) for equity and bond instruments, adding further instruments.
EESC urges Parliament and Council to swiftly adopt the Commission proposal on safeguarding competition in air transport19/01/2018 14:25:00
The EESC backs the EC’s proposal on the long-awaited revision of the regulation on safeguarding competition in air transport.
VAT: More flexibility on VAT rates, less red tape for small businesses19/01/2018 13:25:00
The proposals are the final steps of the EC’s overhaul of VAT rules, with the creation of a single EU VAT area to dramatically reduce the €50bn lost to VAT fraud each year in the EU, while supporting business and securing government revenues.